Similarly, in patients with glioblastoma, SLC16A1-AS1 might promote cancer cell proliferation by regulating miR-149 methylation and could be considered a potential diagnostic marker in glioblastoma (Long et al., 2021). Here, SLC16A1 is linked to cancer.